{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:35:02Z","timestamp":1790271302702,"version":"4.1.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"NIH\/NIDDK","award":["RO1-DK133520"],"award-info":[{"award-number":["RO1-DK133520"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s11894-023-00868-7","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T08:02:32Z","timestamp":1681718552000},"page":"106-113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Parkinson\u2019s Disease and Diabetes Mellitus: Synergistic Effects on Pathophysiology and GI Motility"],"prefix":"10.1007","volume":"25","author":[{"given":"Yun","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanush","family":"Shimoga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5843-1220","authenticated-orcid":false,"given":"Amol","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"issue":"5","key":"868_CR1","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"Ea Dorsey","year":"2007","unstructured":"Dorsey Ea, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology. 2007;68(5):384\u20136.","journal-title":"Neurology"},{"issue":"11","key":"868_CR2","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, et al. Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2018;17(11):939\u201353.","journal-title":"Lancet Neurol"},{"key":"868_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11894-018-0609-x","volume":"20","author":"A Sharma","year":"2018","unstructured":"Sharma A, et al. Constipation in Parkinson\u2019s disease: a nuisance or nuanced answer to the pathophysiological puzzle? Curr Gastroenterol Rep. 2018;20:1\u20139.","journal-title":"Curr Gastroenterol Rep"},{"issue":"10","key":"868_CR4","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1093\/brain\/awaa238","volume":"143","author":"J Horsager","year":"2020","unstructured":"Horsager J, et al. Brain-first versus body-first Parkinson\u2019s disease: a multimodal imaging case-control study. Brain. 2020;143(10):3077\u201388.","journal-title":"Brain"},{"key":"868_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00401-013-1214-6","volume":"127","author":"D Hilton","year":"2014","unstructured":"Hilton D, et al. Accumulation of \u03b1-synuclein in the bowel of patients in the pre-clinical phase of Parkinson\u2019s disease. Acta Neuropathol. 2014;127:235\u201341.","journal-title":"Acta Neuropathol"},{"issue":"11","key":"868_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41575-020-0339-z","volume":"17","author":"RA Travagli","year":"2020","unstructured":"Travagli RA, Browning KN, Camilleri M. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. Nat Reviews Gastroenterol Hepatol. 2020;17(11):673\u201385.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"868_CR7","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00401-012-1028-y","volume":"124","author":"K Del Tredici","year":"2012","unstructured":"Del Tredici K, Braak H. Spinal cord lesions in sporadic Parkinson\u2019s disease. Acta Neuropathol. 2012;124:643\u201364.","journal-title":"Acta Neuropathol"},{"key":"868_CR8","doi-asserted-by":"publisher","unstructured":"Kleine Bardenhorst S, Cereda E, Severgnini M, et al. Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis. Eur J Neurol. 2023;00:1\u201314. https:\/\/doi.org\/10.1111\/ene.15671","DOI":"10.1111\/ene.15671"},{"issue":"9","key":"868_CR9","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","volume":"35","author":"H Nishiwaki","year":"2020","unstructured":"Nishiwaki H, et al. Meta-analysis of gut dysbiosis in Parkinson\u2019s disease. Mov Disord. 2020;35(9):1626\u201335.","journal-title":"Mov Disord"},{"issue":"6","key":"868_CR10","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1053\/j.gastro.2022.02.004","volume":"162","author":"GM Mawe","year":"2022","unstructured":"Mawe GM, et al. 2021 workshop: neurodegenerative Diseases in the gut-brain Axis\u2014Parkinson\u2019s Disease. Gastroenterology. 2022;162(6):1574\u201382.","journal-title":"Gastroenterology"},{"key":"868_CR11","doi-asserted-by":"crossref","unstructured":"Okunoye O, et al. Factors associated with hospitalisation among people with Parkinson\u2019s disease\u2013a systematic review and meta-analysis. Parkinsonism Relat Disord. 2020;71:66\u201372.","DOI":"10.1016\/j.parkreldis.2020.02.018"},{"key":"868_CR12","doi-asserted-by":"crossref","unstructured":"\u2022 Chedid V, et al. Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: a pilot pharmacogenetics study. Neurogastroenterol Motil. 2018;30(7):e13313.\u00a0Defined a genetic phenotype that predicts delay in gastric emptying in response to GLP-1 receptor agonists.","DOI":"10.1111\/nmo.13313"},{"issue":"1\u20132","key":"868_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.autneu.2009.04.004","volume":"150","author":"M Cers\u00f3simo","year":"2009","unstructured":"Cers\u00f3simo M, et al. Hyposialorrhea as an early manifestation of Parkinson disease. Auton Neurosci. 2009;150(1\u20132):150\u20131.","journal-title":"Auton Neurosci"},{"issue":"6","key":"868_CR14","doi-asserted-by":"publisher","first-page":"e14280","DOI":"10.1111\/nmo.14280","volume":"34","author":"S Dilmaghani","year":"2022","unstructured":"Dilmaghani S, et al. Severity of dysphagia is associated with hospitalizations and mortality in patients with Parkinson\u2019s disease. Neurogastroenterol Motil. 2022;34(6):e14280.","journal-title":"Neurogastroenterol Motil"},{"key":"868_CR15","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1590\/S1807-59322008000500015","volume":"63","author":"VN Felix","year":"2008","unstructured":"Felix VN, Corr\u00eaa SMA, Soares RJ. A therapeutic maneuver for oropharyngeal dysphagia in patients with Parkinson\u2019s disease. Clinics. 2008;63:661\u20136.","journal-title":"Clinics"},{"issue":"1","key":"868_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/mds.870080115","volume":"8","author":"L Edwards","year":"1993","unstructured":"Edwards L, et al. Gastrointestinal symptoms in Parkinson disease: 18-month follow\u2010up study. Mov disorders: official J Mov Disorder Soc. 1993;8(1):83\u20136.","journal-title":"Mov disorders: official J Mov Disorder Soc"},{"issue":"1","key":"868_CR17","doi-asserted-by":"publisher","first-page":"e000118","DOI":"10.1136\/bmjgast-2016-000118","volume":"3","author":"A Su","year":"2016","unstructured":"Su A, et al. Utility of high-resolution anorectal manometry and wireless motility capsule in the evaluation of patients with Parkinson\u2019s disease and chronic constipation. BMJ Open Gastroenterol. 2016;3(1):e000118.","journal-title":"BMJ Open Gastroenterol"},{"issue":"12","key":"868_CR18","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/apt.16369","volume":"53","author":"A Sharma","year":"2021","unstructured":"Sharma A, et al. Diagnosis, management and patient perspectives of the spectrum of constipation disorders. Aliment Pharmacol Ther. 2021;53(12):1250\u201367.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"868_CR19","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/mds.21243","volume":"22","author":"R Zangaglia","year":"2007","unstructured":"Zangaglia R, et al. Macrogol for the treatment of constipation in Parkinson\u2019s disease. A randomized placebo-controlled study. Mov disorders: official J Mov Disorder Soc. 2007;22(9):1239\u201344.","journal-title":"Mov disorders: official J Mov Disorder Soc"},{"issue":"21","key":"868_CR20","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182574f28","volume":"78","author":"WG Ondo","year":"2012","unstructured":"Ondo WG, et al. Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease. Neurology. 2012;78(21):1650\u20134.","journal-title":"Neurology"},{"issue":"1","key":"868_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.gtc.2021.10.004","volume":"51","author":"A Sharma","year":"2022","unstructured":"Sharma A, et al. Dyssynergic defecation and other evacuation disorders. Gastroenterol Clin. 2022;51(1):55\u201369.","journal-title":"Gastroenterol Clin"},{"issue":"6","key":"868_CR22","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(20)30842-8","volume":"158","author":"A Sharma","year":"2020","unstructured":"Sharma A, et al. 353 Parkinson\u2019s disease: an efferent brain-gut disorder with severe anorectal hyposensitivity. Gastroenterology. 2020;158(6):S-65.","journal-title":"Gastroenterology"},{"key":"868_CR23","doi-asserted-by":"crossref","unstructured":"Rao SS, et al. Barostat or syringe-assisted sensory biofeedback training for constipation with rectal hyposensitivity: a randomized controlled trial. Neurogastroenterol Motil. 2022;33(3):e14226.","DOI":"10.1111\/nmo.14226"},{"key":"868_CR24","doi-asserted-by":"crossref","unstructured":"Siddiqui M, et al. Autonomic dysfunction in Parkinson\u2019s disease: a comprehensive symptom survey. Parkinsonism Relat Disord. 2002;8(4):277\u201384.","DOI":"10.1016\/S1353-8020(01)00052-9"},{"issue":"2","key":"868_CR25","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1002\/mds.870060211","volume":"6","author":"L Edwards","year":"1991","unstructured":"Edwards L, et al. Gastrointestinal symptoms in Parkinson\u2019s disease. Mov disorders: official J Mov Disorder Soc. 1991;6(2):151\u20136.","journal-title":"Mov disorders: official J Mov Disorder Soc"},{"issue":"7","key":"868_CR26","doi-asserted-by":"publisher","first-page":"S","DOI":"10.1016\/S0016-5085(22)61800-6","volume":"162","author":"Y Yan","year":"2022","unstructured":"Yan Y, et al. Mo1408: Delayed gastric emptying without gastroparesis symptoms in Parkinson\u2019s disease: is PD a DBGI? Gastroenterology. 2022;162(7):S-761.","journal-title":"Gastroenterology"},{"issue":"5","key":"868_CR27","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.parkreldis.2015.01.017","volume":"21","author":"V Low","year":"2015","unstructured":"Low V, et al. Measuring the burden and mortality of hospitalisation in Parkinson\u2019s disease: a cross-sectional analysis of the English Hospital Episodes Statistics database 2009\u20132013. Parkinsonism Relat Disord. 2015;21(5):449\u201354.","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"868_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.parkreldis.2011.12.004","volume":"18","author":"ZS Heetun","year":"2012","unstructured":"Heetun ZS, Quigley EM. Gastroparesis and Parkinson\u2019s disease: a systematic review. Parkinsonism Relat Disord. 2012;18(5):433\u201340.","journal-title":"Parkinsonism Relat Disord"},{"key":"868_CR29","doi-asserted-by":"publisher","unstructured":"Siebner TH, Fuglsang S, Madelung CF, L\u00f8kkegaard A, Bendtsen F, Hove JD, Damgaard M, Madsen JL, Siebner HR. Gastric emptying is not delayed and does not correlate with attenuated postprandial blood flow increase in medicated patients with early Parkinson's Disease. Front Neurol. 2022;13:828069. https:\/\/doi.org\/10.3389\/fneur.2022.828069","DOI":"10.3389\/fneur.2022.828069"},{"issue":"2","key":"868_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/003655200750024317","volume":"35","author":"J Ricci","year":"2000","unstructured":"Ricci J, et al. Upper gastrointestinal symptoms in a US national sample of adults with diabetes. Scand J Gastroenterol. 2000;35(2):152\u20139.","journal-title":"Scand J Gastroenterol"},{"key":"868_CR31","doi-asserted-by":"crossref","unstructured":"Bharucha AE, et al. Relationship between clinical features and gastric emptying disturbances in diabetes mellitus. Clin Endocrinol. 2009;70(3):415\u201320.","DOI":"10.1111\/j.1365-2265.2008.03351.x"},{"key":"868_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF00265086","volume":"32","author":"M Horowitz","year":"1989","unstructured":"Horowitz M, et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1989;32:151\u20139.","journal-title":"Diabetologia"},{"issue":"1","key":"868_CR33","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41395-018-0234-1","volume":"114","author":"V Chedid","year":"2019","unstructured":"Chedid V, et al. Characterization of upper gastrointestinal symptoms, gastric motor functions, and associations in patients with diabetes at a referral center. Off J Am Coll Gastroenterol ACG. 2019;114(1):143\u201354.","journal-title":"Off J Am Coll Gastroenterol ACG"},{"issue":"11","key":"868_CR34","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.2337\/diacare.14.11.1086","volume":"14","author":"W Rathmann","year":"1991","unstructured":"Rathmann W, et al. Visceral afferent neuropathy in diabetic gastroparesis. Diabetes Care. 1991;14(11):1086\u20139.","journal-title":"Diabetes Care"},{"issue":"11","key":"868_CR35","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.2337\/dc13-0347","volume":"36","author":"C Brock","year":"2013","unstructured":"Brock C, et al. Diabetic autonomic neuropathy affects symptom generation and brain-gut axis. Diabetes Care. 2013;36(11):3698\u2013705.","journal-title":"Diabetes Care"},{"issue":"14","key":"868_CR36","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1016\/j.cell.2022.05.007","volume":"185","author":"T Zhang","year":"2022","unstructured":"Zhang T, et al. An inter-organ neural circuit for appetite suppression. Cell. 2022;185(14):2478\u201394.","journal-title":"Cell"},{"key":"868_CR37","doi-asserted-by":"publisher","unstructured":"Karunaratne T,Yan Y, Eubanks A, Inman B, Rao S, Sharma A.\nThoracic spinal nerve neuromodulation therapy for diabetic gastroparesis: a proof-of-concept study.\nClin Gastroenterol Hepatol. 2022. https:\/\/doi.org\/10.1016\/j.cgh.2022.09.012","DOI":"10.1016\/j.cgh.2022.09.012"},{"issue":"11","key":"868_CR38","first-page":"637","volume":"32","author":"P Enck","year":"1994","unstructured":"Enck P, et al. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol. 1994;32(11):637\u201341.","journal-title":"Z Gastroenterol"},{"key":"868_CR39","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/BF02055611","volume":"38","author":"S Sharma","year":"1995","unstructured":"Sharma S, et al. Colorectal manifestations of endocrine disease. Dis Colon Rectum. 1995;38:318\u201323.","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"868_CR40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1572-0241.2001.03350.x","volume":"96","author":"NJ Talley","year":"2001","unstructured":"Talley NJ, et al. Impact of chronic gastrointestinal symptoms in diabetes mellitus on health-related quality of life. Am J Gastroenterol. 2001;96(1):71\u20136.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"868_CR41","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1023\/A:1026657426396","volume":"43","author":"D Maleki","year":"1998","unstructured":"Maleki D, et al. Pilot study of pathophysiology of constipation among community diabetics. Dig Dis Sci. 1998;43(11):2373\u20138.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"868_CR42","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1136\/gutjnl-2012-302483","volume":"62","author":"AE Bharucha","year":"2013","unstructured":"Bharucha AE, et al. A randomised controlled study of the effect of cholinesterase inhibition on colon function in patients with diabetes mellitus and constipation. Gut. 2013;62(5):708\u201315.","journal-title":"Gut"},{"issue":"2","key":"868_CR43","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ajg.2016.531","volume":"112","author":"J Christie","year":"2017","unstructured":"Christie J, et al. A randomized, double-blind, placebo-controlled trial to examine the effectiveness of lubiprostone on constipation symptoms and colon transit time in diabetic patients. Off J Am Coll Gastroenterol ACG. 2017;112(2):356\u201364.","journal-title":"Off J Am Coll Gastroenterol ACG"},{"key":"868_CR44","doi-asserted-by":"crossref","unstructured":"Hishida Y, et al. Effects of Elobixibat in patients with diabetes and concomitant chronic constipation: an 8-week, prospective, Single-center, single-arm study. Adv Ther.\u00a02022;39(9):4205\u201317.","DOI":"10.1007\/s12325-022-02243-w"},{"issue":"6","key":"868_CR45","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1053\/j.gastro.2018.01.062","volume":"154","author":"SB Menees","year":"2018","unstructured":"Menees SB, et al. Prevalence of and factors associated with fecal incontinence: results from a population-based survey. Gastroenterology. 2018;154(6):1672\u201381.","journal-title":"Gastroenterology"},{"key":"868_CR46","unstructured":"Sharma A, Rao SS. Epidemiologic trends and diagnostic evaluation of fecal incontinence. Gastroenterol Hepatol. 2020;16(6):302."},{"issue":"2","key":"868_CR47","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/mds.27922","volume":"35","author":"SM Jeong","year":"2020","unstructured":"Jeong SM, et al. Body mass index, diabetes, and the risk of Parkinson\u2019s disease. Mov Disord. 2020;35(2):236\u201344.","journal-title":"Mov Disord"},{"issue":"5","key":"868_CR48","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.2337\/dc10-1333","volume":"34","author":"E Schernhammer","year":"2011","unstructured":"Schernhammer E, et al. Diabetes and the risk of developing Parkinson\u2019s disease in Denmark. Diabetes Care. 2011;34(5):1102\u20138.","journal-title":"Diabetes Care"},{"key":"868_CR49","doi-asserted-by":"crossref","unstructured":"\u2022 Brauer R, et al. Diabetes medications and risk of Parkinson\u2019s disease: a cohort study of patients with diabetes. Brain. 2020;143(10):3067\u201376.\u00a0Population-based study comparing different anti-diabetic medications on risk of developing Parkinson\u2019s disease.","DOI":"10.1093\/brain\/awaa262"},{"issue":"2","key":"868_CR50","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1212\/WNL.0000000000005771","volume":"91","author":"E De Pablo-Fernandez","year":"2018","unstructured":"De Pablo-Fernandez E, et al. Association between diabetes and subsequent Parkinson disease: a record-linkage cohort study. Neurology. 2018;91(2):e139-42.","journal-title":"Neurology"},{"issue":"8","key":"868_CR51","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1002\/mds.29122","volume":"37","author":"D Athauda","year":"2022","unstructured":"Athauda D, et al. The impact of type 2 diabetes in Parkinson\u2019s disease. Mov Disord. 2022;37(8):1612\u201323.","journal-title":"Mov Disord"},{"issue":"5","key":"868_CR52","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.parkreldis.2013.01.016","volume":"19","author":"V Kotagal","year":"2013","unstructured":"Kotagal V, et al. Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism Relat Disord. 2013;19(5):522\u20136.","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"868_CR53","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.parkreldis.2014.10.008","volume":"20","author":"NI Bohnen","year":"2014","unstructured":"Bohnen NI, et al. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease. Parkinsonism Relat Disord. 2014;20(12):1394\u20138.","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"868_CR54","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3233\/JPD-181305","volume":"8","author":"E Hogg","year":"2018","unstructured":"Hogg E, et al. High prevalence of undiagnosed insulin resistance in non-diabetic subjects with Parkinson\u2019s disease. J Parkinson\u2019s disease. 2018;8(2):259\u201365.","journal-title":"J Parkinson\u2019s disease"},{"issue":"6","key":"868_CR55","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/mds.28545","volume":"36","author":"I Markaki","year":"2021","unstructured":"Markaki I, et al. Euglycemia indicates favorable motor outcome in Parkinson\u2019s disease. Mov Disord. 2021;36(6):1430\u20134.","journal-title":"Mov Disord"},{"issue":"8","key":"868_CR56","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1002\/mds.28689","volume":"36","author":"S Zittel","year":"2021","unstructured":"Zittel S, et al. HbA1c and motor outcome in Parkinson\u2019s disease in the Mark-PD study. Mov Disord. 2021;36(8):1991\u20132.","journal-title":"Mov Disord"},{"issue":"2","key":"868_CR57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/mds.28829","volume":"37","author":"B Huxford","year":"2022","unstructured":"Huxford B, et al. Parkinson\u2019s disease and type 2 diabetes: HbA1c is associated with motor and cognitive severity. Mov Disord. 2022;37(2):427\u20138.","journal-title":"Mov Disord"},{"issue":"5999","key":"868_CR58","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1126\/science.1195227","volume":"329","author":"J Burr\u00e9","year":"2010","unstructured":"Burr\u00e9 J, et al. \u03b1-Synuclein promotes SNARE-complex assembly in vivo and in vitro. Science. 2010;329(5999):1663\u20137.","journal-title":"Science"},{"key":"868_CR59","doi-asserted-by":"crossref","unstructured":"\u2022 Koenig A, Vicente H, Miranda, Outeiro TF. Alpha-synuclein glycation and the action of anti-diabetic agents in Parkinson\u2019s disease. J Parkinson\u2019s disease. 2018;8(1):33\u201343.\u00a0Provides tissue evidence for acceleration of pathology in Parkinson\u2019s patients with diabetes.","DOI":"10.3233\/JPD-171285"},{"issue":"1","key":"868_CR60","doi-asserted-by":"publisher","first-page":"e12760","DOI":"10.1111\/nan.12760","volume":"48","author":"F Bassil","year":"2022","unstructured":"Bassil F, et al. Impaired brain insulin signalling in Parkinson\u2019s disease. Neuropathol Appl Neurobiol. 2022;48(1):e12760.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"6","key":"868_CR61","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/mds.29009","volume":"37","author":"M Uyar","year":"2022","unstructured":"Uyar M, et al. Diabetes, glycated hemoglobin (HbA1c), and neuroaxonal damage in Parkinson\u2019s disease (MARK-PD study). Mov Disord. 2022;37(6):1299\u2013304.","journal-title":"Mov Disord"},{"key":"868_CR62","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jns.2017.04.010","volume":"377","author":"M Ong","year":"2017","unstructured":"Ong M, et al. Influence of diabetes mellitus on longitudinal atrophy and cognition in Parkinson\u2019s disease. J Neurol Sci. 2017;377:122\u20136.","journal-title":"J Neurol Sci"},{"issue":"5","key":"868_CR63","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.acra.2015.07.014","volume":"23","author":"M Petrou","year":"2016","unstructured":"Petrou M, et al. Diabetes, gray matter loss, and cognition in the setting of Parkinson disease. Acad Radiol. 2016;23(5):577\u201381.","journal-title":"Acad Radiol"},{"issue":"7","key":"868_CR64","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun SP, et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat Med. 2018;24(7):931\u20138.","journal-title":"Nat Med"},{"key":"868_CR65","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","volume":"145","author":"D Athauda","year":"2016","unstructured":"Athauda D, Foltynie T. Insulin resistance and Parkinson\u2019s disease: a new target for disease modification? Prog Neurobiol. 2016;145:98\u2013120.","journal-title":"Prog Neurobiol"},{"issue":"6","key":"868_CR66","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1172\/JCI68295","volume":"123","author":"I Aviles-Olmos","year":"2013","unstructured":"Aviles-Olmos I, et al. Exenatide and the treatment of patients with Parkinson\u2019s disease. J Clin Investig. 2013;123(6):2730\u20136.","journal-title":"J Clin Investig"},{"issue":"3","key":"868_CR67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3233\/JPD-140364","volume":"4","author":"I Aviles-Olmos","year":"2014","unstructured":"Aviles-Olmos I, et al. Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson\u2019s disease. J Parkinson\u2019s disease. 2014;4(3):337\u201344.","journal-title":"J Parkinson\u2019s disease"},{"key":"868_CR68","doi-asserted-by":"crossref","unstructured":"\u2022 Athauda D, et al. Exenatide once weekly versus placebo in Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial. The Lancet. 2017;390(10103):1664\u201375.\u00a0Randomized, placebo-controlled trial demonstrating efficacy of exenatide in Parkinson\u2019s disease with diabetes.","DOI":"10.1016\/S0140-6736(17)31585-4"},{"issue":"2","key":"868_CR69","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3233\/JPD-181329","volume":"8","author":"D Athauda","year":"2018","unstructured":"Athauda D, et al. What effects might exenatide have on non-motor symptoms in Parkinson\u2019s disease: a post hoc analysis. J Parkinson\u2019s disease. 2018;8(2):247\u201358.","journal-title":"J Parkinson\u2019s disease"},{"issue":"6","key":"868_CR70","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/0168-5597(91)90130-P","volume":"80","author":"V Loening-Baucke","year":"1991","unstructured":"Loening-Baucke V, Read NW, Yamada T. Cerebral evoked potentials after rectal stimulation. Electroencephalogr Clin Neurophysiol\/Evoked Potentials Sect. 1991;80(6):490\u20135.","journal-title":"Electroencephalogr Clin Neurophysiol\/Evoked Potentials Sect"},{"issue":"2","key":"868_CR71","doi-asserted-by":"publisher","first-page":"G335","DOI":"10.1152\/ajpgi.00230.2001","volume":"283","author":"DI Hobday","year":"2002","unstructured":"Hobday DI, et al. Cortical processing of human gut sensation: an evoked potential study. Am J Physiol-Gastrointestinal Liver Physiol. 2002;283(2):G335-9.","journal-title":"Am J Physiol-Gastrointestinal Liver Physiol"},{"issue":"12","key":"868_CR72","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1177\/000348940811701210","volume":"117","author":"PC Belafsky","year":"2008","unstructured":"Belafsky PC, et al. Validity and reliability of the Eating Assessment Tool (EAT-10). Ann Otol Rhinol Laryngol. 2008;117(12):919\u201324.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"868_CR73","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00221-006-0480-0","volume":"174","author":"AM Drewes","year":"2006","unstructured":"Drewes AM, et al. The \u201chuman visceral homunculus\u201d to pain evoked in the oesophagus, stomach, duodenum and sigmoid colon. Exp Brain Res. 2006;174:443\u201352.","journal-title":"Exp Brain Res"},{"issue":"8","key":"868_CR74","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1111\/j.1572-0241.2001.04088.x","volume":"96","author":"Y Chan","year":"2001","unstructured":"Chan Y, et al. Alterations in cerebral potentials evoked by rectal distension in irritable bowel syndrome. Am J Gastroenterol. 2001;96(8):2413\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"868_CR75","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1016\/S0002-9270(01)02515-1","volume":"96","author":"P Sinhamahapatra","year":"2001","unstructured":"Sinhamahapatra P, et al. Visceral afferent hypersensitivity in irritable bowel syndrome\u2014evaluation by cerebral evoked potential after rectal stimulation. Am J Gastroenterol. 2001;96(7):2150\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"868_CR76","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1365-2982.2010.01619.x","volume":"23","author":"JM Remes-Troche","year":"2011","unstructured":"Remes-Troche JM, et al. A bi-directional assessment of the human brain\u2010anorectal axis. Neurogastroenterol Motil. 2011;23(3):240-e118.","journal-title":"Neurogastroenterol Motil"},{"issue":"4","key":"868_CR77","doi-asserted-by":"publisher","first-page":"e13769","DOI":"10.1111\/nmo.13769","volume":"32","author":"A Gottfried-Blackmore","year":"2020","unstructured":"Gottfried-Blackmore A, et al. Open-label pilot study: non\u2010invasive vagal nerve stimulation improves symptoms and gastric emptying in patients with idiopathic gastroparesis. Neurogastroenterol Motil. 2020;32(4):e13769.","journal-title":"Neurogastroenterol Motil"},{"issue":"12","key":"868_CR78","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1111\/apt.15772","volume":"51","author":"SS Rao","year":"2020","unstructured":"Rao SS, et al. Randomised clinical trial: linaclotide vs placebo\u2014a study of bi-directional gut and brain axis. Aliment Pharmacol Ther. 2020;51(12):1332\u201341.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-023-00868-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11894-023-00868-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-023-00868-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T21:23:48Z","timestamp":1682717028000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11894-023-00868-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":78,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["868"],"URL":"https:\/\/doi.org\/10.1007\/s11894-023-00868-7","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"14 March 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"AS served on the advisory board for Phathom Pharmaceuticals, Takeda Pharmaceuticals, Salix Pharmaceuticals, and Ironwood Pharmaceuticals. He has received research funding from Vibrant Ltd, Parkinson\u2019s Foundation, and NIDDK.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}